Status:
TERMINATED
Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Lung Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Cisplatin is a widely used anti-tumor agent for the treatment of testicular and ovarian cancers. Carboplatin is used extensively for small cell, non small cell lung cancer and ovarian cancer. Oxalipla...
Detailed Description
Cisplatin, cis-\[Pt(NH3)2Cl2\], is a widely used antitumor agent for the treatment of testicular and ovarian cancers. Carboplatin is used extensively for small cell, non small cell lung cancer and ova...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- To have lung or colorectal cancer and be treated with either oxaliplatin, carboplatin or cisplatin
Exclusion
Key Trial Info
Start Date :
April 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00131586
Start Date
April 1 2003
End Date
February 1 2009
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2